Hapten-IgG-induced suppression of the in vitro antibody response: role of hapten density and of antigenic challenge.
D000917:Antibody Formation; D000941:Antigens; D001402:B-Lymphocytes / Q000276:immunology; D002478:Cells, Cultured; D004912:Erythrocytes / Q000276:immunology; D006241:Haptens; D007140:Immunoglobulin Fab Fragments; D007141:Immunoglobulin Fc Fragments; D007074:Immunoglobulin G; D007165:Immunosuppression Therapy; D008070:Lipopolysaccharides / Q000494:pharmacology; D012709:Serum Albumin / Q000494:pharmacology; D013154:Spleen / Q000276:immunology; D013329:Structure-Activity Relationship; D013601:T-Lymphocytes / Q000276:immunology; D013696:Temperature; D013997:Time Factors; D014301:Trinitrobenzenes / Q000276:immunology; D001613:beta 2-Microglobulin / Q000494:pharmacology
D000941:Antigens; D006241:Haptens; D007140:Immunoglobulin Fab Fragments; D007141:Immunoglobulin Fc Fragments; D007074:Immunoglobulin G; D008070:Lipopolysaccharides; D012709:Serum Albumin; D014301:Trinitrobenzenes; D001613:beta 2-Microglobulin